Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06382662 · ClinicalTrials.gov registry record · Phase 4
Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition
A Phase 4 study, sponsored by Primus Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT06382662 is a Phase 4 study that has completed, run by Primus Pharmaceuticals. The registered enrollment target is 20 participants.
The verdict
NCT06382662, a Phase 4 study, has completed, sponsored by Primus Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Every participant will receive active study drug and one (1 )comparator, in two (2) stages, one after the other. Each drug will be taken one (1) time after a high fat meal. Vital signs and discussion of medications, illness or injury are considered safety assessments and will be discussed at every visit. There will be ( four (4) visits.
Interventions
- DRUG metaxalone m640
- DRUG tizanidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2025-03-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06382662
The ClinicalTrials.gov registry entry for NCT06382662 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Primus Pharmaceuticals, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metaxalone m640 is the first listed.
NCT06382662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06382662 about?
NCT06382662 is a clinical study titled "Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition". Every participant will receive active study drug and one (1 )comparator, in two (2) stages, one after the other. Each drug will be taken one (1) time after a high fat meal. Vital signs and discussion of medications, illness or injury are considered safety assessments and will be discussed at every v...
What is the current status of trial NCT06382662?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-04-29. Estimated completion is 2025-03-06.
What interventions are being tested in trial NCT06382662?
The interventions under investigation include: metaxalone m640 (DRUG), tizanidine (DRUG).
Who is sponsoring clinical trial NCT06382662?
This trial is sponsored by Primus Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.